Last news
Bitget October 2025 Protection Fund Maintains $741M Average Despite Slumptober

Bitget October 2025 Protection Fund Maintains $741M Average Despite Slumptober

Notified -...

Geneva College of Longevity Science and DrVibe.ai Launch the GCLS AI Academy for Longevity Sciences

Geneva College of Longevity Science and DrVibe.ai Launch the GCLS AI Academy for Longevity Sciences

Notified -...

EBC Financial Group Recognised as Best Broker for Execution at Professional Trader Awards 2025

EBC Financial Group Recognised as Best Broker for Execution at Professional Trader Awards 2025

Notified -...

Private Healthcare Costs Are Rewriting the Map for Migrating Millionaires, New Data Shows

Private Healthcare Costs Are Rewriting the Map for Migrating Millionaires, New Data Shows

Notified -...

SHELL PLC THIRD QUARTER 2025 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS

SHELL PLC THIRD QUARTER 2025 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS

Notified -...

NOTICE TO DISREGARD -- ICARO Media Group

NOTICE TO DISREGARD -- ICARO Media Group

Notified -...

Digital Realty Announces Access to Oracle Cloud Infrastructure in Singapore via FastConnect

Digital Realty Announces Access to Oracle Cloud Infrastructure in Singapore via FastConnect

Notified -...

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

Notified -...

1 ... 6 7 8 9 10 11 12 13 14 ... 971
menu
menu